Cartesian Therapeutics Inc (RNAC)

Retained Earnings

-$845.79M

Quarterly · Period ending: · USD

RNAC logo

RNAC Retained Earnings

Latest reported-$845.79M
RNAC Quarterly Retained Earnings (-$111.51M → -$845.79M)
High-resolution chart · PNG

RNAC retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-845,786,000
-861,555,000
-822,373,000
-729,797,000
-693,895,000
-709,781,000
-692,071,000
-681,818,000
-657,635,000
-671,471,000
-614,647,000
-436,989,000
-427,987,000
-416,600,000
-394,937,000
-400,830,000
-392,937,000
-401,538,000
-430,316,000
-442,555,000
-424,661,000
-429,226,000
-404,629,000
-389,183,000
-379,454,000
-355,373,000
-335,753,000
-320,865,000
-308,871,000
-292,477,000
-280,403,000
-263,154,000
-247,153,000
-228,357,000
-216,897,000
-197,353,000
-182,677,000
-166,710,000
-151,576,000
-137,493,000
-129,765,000
-121,051,000
-111,508,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.